盈康生命(300143.SZ):国华腾达拟协议转让7.43%股份予天津源和
格隆汇9月2日丨盈康生命(300143.SZ)公布,公司于近日收到了持股5%以上股东国华腾达和股东天津源和出具的《简式权益变动报告书》,获悉国华腾达与天津源和于2019年8月30日签署了《股份转让协议》,国华腾达拟将其持有的盈康生命约4056.94万股(占公司总股本的7.43%)无限售流通股(“标的股份”)转让给天津源和。标的股份的每股转让价格为人民币7.3948元,标的股份转让价款总额为每股转让价格与标的股份数量的乘积,为人民币300,002,562元,经协商确定股份转让价款总额为人民币3亿元。
此次权益变动前,国华腾达持有盈康生命约4056.94万股股份,占公司总股本7.43%;天津源和持有盈康生命903.85万股股份,占公司总股本1.66%。此次权益变动后,国华腾达持有盈康生命0股股份,占公司总股本0%;天津源和持有盈康生命约4960.79万股股份,占公司总股本9.09%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.